跳到正文
可穿戴与测量科学随机对照试验3 分钟阅读

慢阻肺的手机应用加活动手环:前景可期,但可行性试验中47%退出

MoveVitals 编辑部 · 研究发表 · 解读更新

原文:The Use of a Smartphone App and an Activity Tracker to Promote Physical Activity in the Management of Chronic Obstructive Pulmonary Disease: Randomized Controlled Feasibility Study. · JMIR mHealth and uHealth · 2020 · 论文原文 ↗

先看重点

在一项纳入30名慢阻肺患者的可行性试验中,47%(14/30)退出,常见原因是技术难以使用,但留下来的人大多评价正面。该试验旨在检验大型试验是否可行,而非证明获益,且完成者健康状况更好、更熟悉数字技术。

证据类型

随机对照试验

解读依据

公开摘要

阅读重点

对照与不确定性

研究在问什么

保持活动对慢性阻塞性肺疾病(慢阻肺)患者有益,但许多人在肺康复结束后活动量下降。研究者检验了智能手机应用加活动追踪器(SMART-COPD)用于维持活动是否可接受、好用,以及开展正式大型试验是否可行。

研究了谁,如何研究

随机可行性研究,30名慢阻肺患者被分入SMART-COPD干预组(n=19)或对照组(n=11)。参与者在整个肺康复期间及之后8周内使用应用和追踪器设定活动目标并监测进展。分别在基线、肺康复结束和维持期结束时收集问卷和活动结局。研究还访谈了参与者及参与肺康复的医务人员。

主要发现

以下为作者报告的结果。数字须连同人群和不确定性一起阅读。

  1. 1
    总体上,47%(14/30)的参与者退出,常见原因是使用技术有困难。
  2. 2
    与退出者相比,完成研究者基线健康状况更好,之前使用数字技术的经验也更多。
  3. 3
    完成者总体评价正面,觉得技术容易使用,部分人觉得它对健康和实现活动目标有帮助。
  4. 4
    追踪器数据和自我报告作为身体活动的评估方式都有问题,部分对照组成员对分组感到不满。

局限与不确定性

  1. 1
    只有30名参与者且近半退出,所报告的体验来自一个自我筛选的、更健康也更熟悉技术的群体。
  2. 2
    可行性试验并非为估计疗效而设计,摘要也未报告活动量或健康方面的效应估计。
  3. 3
    活动追踪器和自我报告都不适合作为结局指标,这限制了此类试验能证明的内容。
  4. 4
    本解读仅基于摘要。

对日常健康的启示

这提示对慢阻肺患者来说,应用加追踪器的支持对不少人可以接受,但对所有人还不够简单,可能更适合熟悉技术、病程较早的人。这并不能证明该方案可提高活动量。关于慢阻肺的运动问题,应向主治医生或康复团队咨询。

如何联系自己的数据

本研究中追踪器的步数很难作为可靠的结局指标,这提醒你:同一设备戴在同一手腕,比较自己每周平均步数的变化,而不是看单日数据。如果设备或应用成了负担,坚持得下去的简单记录比复杂设置更好。

如何理解这类证据

随机分组有助于因果推断,仍须检查分配、盲法、失访、随访时间和具体对照;标为随机试验不自动意味着高确定性。

作者的结构化摘要 English

以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。

Background

Chronic obstructive pulmonary disease (COPD) is highly prevalent and significantly affects the daily functioning of patients. Self-management strategies, including increasing physical activity, can help people with COPD have better health and a better quality of life. Digital mobile health (mHealth) techniques have the potential to aid the delivery of self-management interventions for COPD. We developed an mHealth intervention (Self-Management supported by Assistive, Rehabilitative, and Telehealth technologies-COPD [SMART-COPD]), delivered via a smartphone app and an activity tracker, to help people with COPD maintain (or increase) physical activity after undertaking pulmonary rehabilitation (PR).

Objective

This study aimed to determine the feasibility and acceptability of using the SMART-COPD intervention for the self-management of physical activity and to explore the feasibility of conducting a future randomized controlled trial (RCT) to investigate its effectiveness.

Methods

We conducted a randomized feasibility study. A total of 30 participants with COPD were randomly allocated to receive the SMART-COPD intervention (n=19) or control (n=11). Participants used SMART-COPD throughout PR and for 8 weeks afterward (ie, maintenance) to set physical activity goals and monitor their progress. Questionnaire-based and physical activity-based outcome measures were taken at baseline, the end of PR, and the end of maintenance. Participants, and health care professionals involved in PR delivery, were interviewed about their experiences with the technology.

Results

Overall, 47% (14/30) of participants withdrew from the study. Difficulty in using the technology was a common reason for withdrawal. Participants who completed the study had better baseline health and more prior experience with digital technology, compared with participants who withdrew. Participants who completed the study were generally positive about the technology and found it easy to use. Some participants felt their health had benefitted from using the technology and that it assisted them in achieving physical activity goals. Activity tracking and self-reporting were both found to be problematic as outcome measures of physical activity for this study. There was dissatisfaction among some control group members regarding their allocation.

Conclusions

mHealth shows promise in helping people with COPD self-manage their physical activity levels. mHealth interventions for COPD self-management may be more acceptable to people with prior experience of using digital technology and may be more beneficial if used at an earlier stage of COPD. Simplicity and usability were more important for engagement with the SMART-COPD intervention than personalization; therefore, the intervention should be simplified for future use. Future evaluation will require consideration of individual factors and their effect on mHealth efficacy and use; within-subject comparison of step count values; and an opportunity for control group participants to use the intervention if an RCT were to be carried out. Sample size calculations for a future evaluation would need to consider the high dropout rates.

来源与署名

The Use of a Smartphone App and an Activity Tracker to Promote Physical Activity in the Management of Chronic Obstructive Pulmonary Disease: Randomized Controlled Feasibility Study.

Bentley CL, Powell L, Potter S, Parker J, Mountain GA, Bartlett YK, Farwer J, O'Connor C, Burns J, Cresswell RL, Dunn HD, Hawley MS.

JMIR mHealth and uHealth · 2020-06-03

DOI: 10.2196/16203 ↗PubMed · 32490838 ↗Europe PMC · 记录的开放许可: cc by ↗

摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。

MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅

来源核验日期 2026-11-01

实用健康指南

放在一起读

·队列研究

加速度计处理方法不同,身体活动与卒中、心肌梗死的关联曲线也不同

在英国生物银行中,基线无心血管疾病的90237名成年人随访至2022年12月,共发生1298例卒中和2031例心肌梗死;中高强度身体活动(MVPA)与这两种结局的关联曲线形状,取决于加速度计数据的处理方法。就卒中而言,只有机器学习法得到直线下降的风险;就心肌梗死而言,机器学习法和LFENMO法呈曲线下降,活动计数法呈直线下降。摘要没有给出风险比,只能说明不同方法的结论不一致,不能说明哪种方法更正确,而且这些只是观察性关联。

Preventive Medicine

重点论文精讲阅读论文 →
·测量验证研究/综述

智能手表数据能当“证人”吗:心率验证得最充分,其余证据参差

一项围绕数字取证展开的系统评价和荟萃分析,梳理了四大主流品牌智能手表的验证研究,发现心率是研究最多、也最准确的指标。步数、距离、能量消耗、活动分类和睡眠的验证不够一致,结果因品牌、方案和报告方式而异。摘要没有给出汇总数据,且多数研究是在健康人群中、于实验室内完成的,所以无法说明某一块手表对某个人在日常生活中的表现。

Forensic Science International

重点论文精讲阅读论文 →
·综述的综述

活动追踪器:每天多走约1800步,对其他健康指标影响较小

这项伞形综述汇总了39篇系统评价和荟萃分析,涉及163992名参与者;结果显示使用活动追踪器与身体活动增加相关(标准化均数差SMD为0.3–0.6),相当于每天多走约1800步、多步行40分钟,体重减轻约1公斤。对血压、胆固醇、糖化血红蛋白、生活质量和疼痛的影响通常很小,且多数不显著。摘要没有说明这些项目里追踪器还搭配了什么,也没有说明各评价之间重叠多少,因此不能把效果完全归功于设备本身。

The Lancet Digital Health

重点论文精讲阅读论文 →
·测量验证研究/综述

七款睡眠追踪设备:识别睡着很准,识别醒着和睡眠分期较差

在睡眠实验室里,34名健康的年轻成年人连续三晚佩戴七款消费级睡眠追踪设备中的若干款。与多导睡眠监测相比,所有设备识别睡眠都很准(灵敏度均不低于0.93),但识别清醒较差(特异度0.18–0.54),七款中有五款与研究用活动记录仪(特异度0.39)持平或更好;睡眠分期的估计结果不稳定。受试者是18至35岁的健康成年人,卧床时间固定为8小时,每款设备只在其中11至20人身上测试,因此对有睡眠问题的人几乎没有参考价值。

Sleep

重点论文精讲阅读论文 →
可穿戴与测量科学 →